Multiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 Diabetics
Status:
Terminated
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of
multiple oral doses of GMC-252-L-Lysine salt (GMC-252) in healthy subjects and type 2
diabetics.
The secondary objective is to explore the effect of multiple oral doses of GMC-252 on
pharmacodynamic(PD) parameters in type 2 diabetics.